{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Zhang SZ"],"funding":["National Science and Technology Major Project for IND (investigational new drug","Capital Health Development Research","Beijing Municipal Commission of Science and Technology Clinical Application Special Fund"],"pagination":["216"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC6617899"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["19(1)"],"pubmed_abstract":["<h4>Background</h4>Data on the pharmacological management of acute agitation in schizophrenia are scarce. The aim of this study is to investigate the prescription practices in the treatment of agitation in Chinese patients with schizophrenia.<h4>Methods</h4>We conducted a large, multicenter, observational study in 14 psychiatry hospitals in China. Newly hospitalized schizophrenia patients with the PANSS-EC total score ≥ 14 and a value ≥4 on at least one of its five items were included in the study. Their drug treatments of the first 2 weeks in hospital were recorded by the researchers.<h4>Results</h4>Eight hundred and 53 patients enrolled in and 847 (99.30%) completed the study. All participants were prescribed antipsychotics, 40 (4.72%) were prescribed benzodiazepine in conjunction with a"],"journal":["BMC psychiatry"],"pubmed_title":["Prescription practices in the treatment of agitation in newly hospitalized Chinese schizophrenia patients: data from a non-interventional naturalistic study."],"pmcid":["PMC6617899"],"funding_grant_id":["2016-2-4112","Z181100001718157","2018ZX09734-005"],"pubmed_authors":["Tan QR","Sang H","Liu Q","Xie SP","Chen ZY","Su ZH","Zhang SZ","Li LZ","Shi Y","Guo LH","Zhang HY","Yang FD","Mei QY","Mu YG","Zhang CP","Li T","He HB","Zhang JB","Liu TB","Wang Y","Mi WF"],"additional_accession":[]},"is_claimable":false,"name":"Prescription practices in the treatment of agitation in newly hospitalized Chinese schizophrenia patients: data from a non-interventional naturalistic study.","description":"<h4>Background</h4>Data on the pharmacological management of acute agitation in schizophrenia are scarce. The aim of this study is to investigate the prescription practices in the treatment of agitation in Chinese patients with schizophrenia.<h4>Methods</h4>We conducted a large, multicenter, observational study in 14 psychiatry hospitals in China. Newly hospitalized schizophrenia patients with the PANSS-EC total score ≥ 14 and a value ≥4 on at least one of its five items were included in the study. Their drug treatments of the first 2 weeks in hospital were recorded by the researchers.<h4>Results</h4>Eight hundred and 53 patients enrolled in and 847 (99.30%) completed the study. All participants were prescribed antipsychotics, 40 (4.72%) were prescribed benzodiazepine in conjunction with a","dates":{"release":"2019-01-01T00:00:00Z","publication":"2019 Jul","modification":"2025-04-04T10:14:09.193Z","creation":"2019-07-30T07:03:28Z"},"accession":"S-EPMC6617899","cross_references":{"pubmed":["31291931"],"doi":["10.1186/s12888-019-2192-6"]}}